343 related articles for article (PubMed ID: 8903655)
1. Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
Halimi JM; Mimran A
J Hypertens; 1995 Dec; 13(12 Pt 2):1801-2. PubMed ID: 8903655
[TBL] [Abstract][Full Text] [Related]
2. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
[TBL] [Abstract][Full Text] [Related]
3. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
Maule S; Mulatero P; Milan A; Leotta G; Caserta M; Bertello C; Rabbia F; Veglio F
J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
[TBL] [Abstract][Full Text] [Related]
4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
5. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
[TBL] [Abstract][Full Text] [Related]
6. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
[TBL] [Abstract][Full Text] [Related]
7. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
8. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
[TBL] [Abstract][Full Text] [Related]
9. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
[TBL] [Abstract][Full Text] [Related]
10. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
11. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.
Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y
Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637
[TBL] [Abstract][Full Text] [Related]
13. The diagnosis of primary aldosteronism and separation of two major subtypes.
Weinberger MH; Fineberg NS
Arch Intern Med; 1993 Sep; 153(18):2125-9. PubMed ID: 8379804
[TBL] [Abstract][Full Text] [Related]
14. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
15. [Effect of insulin in hypertension with high and low levels of renin].
Sindelka G; Widimský J; Prázný M; Kasalová Z; Skrha J
Cas Lek Cesk; 2001 Apr; 140(7):205-8. PubMed ID: 11374224
[TBL] [Abstract][Full Text] [Related]
16. Primary aldosteronism in diabetic subjects with resistant hypertension.
Umpierrez GE; Cantey P; Smiley D; Palacio A; Temponi D; Luster K; Chapman A
Diabetes Care; 2007 Jul; 30(7):1699-703. PubMed ID: 17429062
[TBL] [Abstract][Full Text] [Related]
17. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin and insulin sensitivity in primary aldosteronism.
Fallo F; Della Mea P; Sonino N; Bertello C; Ermani M; Vettor R; Veglio F; Mulatero P
Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
[TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]